Published

Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: BMJ (Clinical research ed.)
Date: 2024-05-01
Source: PubMed
DOI: 10.1136/bmj-2023-078084
PubMed: 38692686

Authors

Metaxa AM Clarke M

Watch author

Derived topics and classifications

psilocybin Depression Clinical Trial Meta-Analysis Systematic Review Review Article Healthcare Workers Safety Meta-Analysis

Citation graph

0 referenced DOIs found in stored source metadata. 13 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

No evidence for deleterious effects of psilocybin and MDMA on working memory or related neurophysiological activity in a non-clinical population: An uncontrolled exploratory study2026-07-23 Past-Year Psilocybin and Alcohol Co-Use: Associations With Mental Health Symptoms2026-07-01 Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex2026-06-28 PSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEW2026-06-24 Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis2026-06-15 Effect of psilocybin-assisted psychotherapy on anxiety symptoms: A systematic review and meta-analysis2026-05-29 Short-Term and Late-Term Effects of Psilocybin on Symptoms in Major Depression2026-05-15 Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care2026-05-14 Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression2026-05-01 Evaluation of a facilitator training program in a randomized controlled trial of psilocybin treatment for depression2026-04-09 A living systematic review, meta-analysis and open-data resource of randomized controlled trials of psilocybin treatment for symptoms of depression2026-04-06 Psychedelics in NHS services: exploring a model for real-world implementation of psilocybin2026-03-30 Psilocybin in Neuropsychiatric Disorders: Seeking Valuable Evidence in History, Pure Science, Clinical Trials and Real-World Data (RWD)2026-03-26

Related papers

G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?Ask the expert - Psychedelic substances · 2024-08-31 Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]ClinicalTrials.gov · 2026-07-21